Adiuwantowa hormonoterapia u chorych na raka piersi
Abstract
Author(s): ANNA BRZOZOWSKA, MARIA MAZURKIEWICZ
Adjuvant hormonal therapy should be a treatment of choice in breast cancer patients with positive level of receptors, both pre- and postmenopausal. Among available methods of hormonal therapy we can choose between antiestrogenic steroids, aromatase inhibitors and LH-RH analogs depending on hormonal status of patient, patients’s chronic diseases and their preferences. In this article, important questions regarding selection of hormonal manipulation, optimal sequence of different methods and duration of hormonal treatment will be discussed.
<Share this article
Editors List
-
Prof. Elhadi Miskeen
Obstetrics and Gynaecology Faculty of Medicine, University of Bisha, Saudi Arabia
-
Ahmed Hussien Alshewered
University of Basrah College of Medicine, Iraq
-
Sudhakar Tummala
Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh
-
Alphonse Laya
Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis
-
Fava Maria Giovanna
Google Scholar citation report
Citations : 2495
Onkologia i Radioterapia received 2495 citations as per Google Scholar report
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Scimago
- SCOPUS
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20